Addendum B
`
`Addendum B
`
`INTEL EX. 1401.001
`
`INTEL EX. 1401.001
`
`

`

`Case No- IPR2018-00234
`
`US. Patent No. 8,805,948
`
`Append-ixAddendum A
`Stipulated Protective Order
`
`This s§tipulated pgrotective eQrder governs the treatment and filing of
`protected information, including documents and testimony-
`
`1. Protected information shall be clearly marked “CONFIDENTIAL: er
`“CONFIDENTIAL — ATTORNEYS’ EYES ONLY;’:fl
`“PETITIONER’S RESTRICTED — ATTORNEYS’ EES ONLY.”
`
`2. Access to protected information marked “CONFIDENTIAL” is limited to the
`following individuals who have executed the acknowledgment appended to this
`egrder:
`
`(A) Parties. Persons who are owners of a patent involved in the proceeding and
`other persons who are named parties to the proceeding.
`
`(B) Party Representatives. Representatives of record for a party in the proceeding.
`
`(C) Experts. Retained experts of a party in the proceeding who further certify in the
`Acknowledgement that they are not a competitor to any party, or a consultant for, or
`employed by, such a competitor with respect to the subject matter of the
`proceeding.
`
`0)) In-house counsel. In—house counsel of a party.
`
`03) Other Employees ofa Party. Employees, consultants or other persons
`performing work for a party, other than in-house counsel and in—house counsel’s
`support staff, who sign the Acknowledgement shall be extended access to
`
`protected information only upon agreement of the parties or by order of the Board
`upon a motion brought by the party seeking to disclose protected information to
`that person. The party opposing disclosure to that person shall have the burden of
`proving that such person should be restricted from access to protected information.
`
`(F) The Oflice. Employees and representatives of the Oflice who have a need for
`access to the protected information shall have such access without the requirement
`to sign an Acknowledgement. Such employees and representatives shall include the
`Director, members of the Board and their clerical staff, other support personnel,
`court reporters, and other persons acting on behalf of the Office.
`
`1
`
`INTEL EX. 1401.002
`
`INTEL EX. 1401.002
`
`

`

`Case No. IPR2018-00234
`
`US Patent No. 8,805,948
`W
`
`(G) Support Personnel. Administrative assistants, clerical staff, court reporters and
`other support personnel of the foregoing persons who are reasonably necessary to
`assist those persons in the proceeding shall not be required to sign an
`Acknowledgement,
`but shall be informed of the terms and requirements of the Protective Order by the
`person they are supporting who receives confidential information.
`
`3. Access to protected information marked “CONFIDENTIAL — ATTORNEYS’
`EYES ONLY” is limited to the following individuals who have executed the
`acknowledgement appended to this egrder: outside counsel of record for a party in
`this IPR proceeding, and the individuals identified above in 2(C), 2(D), 2(F), and
`2(G); provided, however, that access by in-house counsel pursuant to paragraph
`2(D) be limited to in—house counsel who exercise no competitive decision-making
`authority on behalf of the client. Such material may include the following types of
`information: (1) sensitive technical information, including current research,
`development and manufacturing information; (2) sensitive business information,
`including highly sensitive financial or marketing information; (3) competitive
`technical information, including technical analyses or comparisons of competitor’s
`products or services; (4) competitive business information, including non-public
`financial and marketing analyses, media scheduling, comparisons of competitor’s
`products or services, and strategic product/service expansion plans; (5) personal
`health or medical information; (6) an individual’s personal credit, banking or other
`financial information; or (7) any other commercially sensitive information the
`disclosure of which to non-qualified persons subject to this Order the producing
`party reasonably and in good faith believes would likely cause harm
`
`
`4. Access to protected information marked “PETITIONER’S RESTRICTED —
`
`ATTORNEYS’ EYES ONLY” is limited to the following individuals who have
`executed the acknowledgement appended to this Order: outside counsel of record
`for the Patent Owner in this IPR proceeding, the petitioner in this IPR proceeding
`
`who produced the information marked “PETITIONER’S RESTRICTED —
`ATTORNEYS’ EYES ONLY”, and the individuals identified above in 2gC 1, 2m,
`and 2; G), provided, however, that access by experts pursuant to paragpaph 2; C) be
`limited to the experts of the Patent Owner in this IPR proceeding and the petitioner
`in this IPR proceeding who produced the information marked “PETITIONER’S
`RESTRICTED — ATTORNEYS’ EYES ONLY.” Such material may include the
`followin
`es of information:
`1 sensitive co
`etitive business information
`
`including customer contracts; or (2) any other commercially sensitive information
`
`2
`
`INTEL EX. 1401.003
`
`INTEL EX. 1401.003
`
`

`

`Case No. IPR2018-00234
`US. Patent No. 8 805 948
`
`the disclosure of which to non-Qualified persons subject to this Ordera including
`
`other petitioners in this IPR proceeding! the producing 9am reasonably and in
`good faith believes would likely cause harm. Notwithstanding this provision;
`outside counsel and in—house counsel for any other petitioner in this IPR
`
`proceeding may attend any oral argflent for this IPR even if “PETITIONER’S
`
`RESTRICTED — ATTORNEYS’ EYES ONLY” information is discussed.
`
`4;. Persons receiving protected information shall use reasonable efforts to maintain
`the confidentiality of the information, including:
`
`(A) Maintaining such information in a secure location to which persons not
`authorized to receive the information shall not have access;
`
`(B) Otherwise using reasonable efforts to maintain the confidentiality of the
`information, which efforts shall be no less rigorous than those the recipient uses to
`maintain the confidentiality of information not received from the disclosing party;
`
`(C) Ensuring that support personnel of the recipient who have access to the
`protected information understand and abide by the obligation to maintain the
`confidentiality of information received that is designated as confidential; and
`
`NW
`
`INTEL EX. 1401.004
`
`INTEL EX. 1401.004
`
`

`

`GasfifloA—PPQ—O—l—S—(W
`
`(D) Limiting the copying of protected information to a reasonable number of
`copies needed for conduct of the proceeding and maintaining a record of the
`locations of such copies.
`
`5; Persons receiving protected information shall use the following procedures
`to maintain the confidentiality of the information:
`
`(A) Documents and Information Filed With the Board.
`
`(i) A party may file documents or information with the Board under seal, together
`with a non-confidential description of the nature of the protected information that is
`under seal and the reasons why the information is confidential and should not be
`made available to the public. The submission shall be treated as confidential and
`remain under seal, unless, upon motion of a party
`and after a hearing on the issue, or sua sponte, the Board determines that the
`documents or information do not to qualify for confidential treatment.
`
`4
`
`INTEL EX. 1401.005
`
`INTEL EX. 1401.005
`
`

`

`Case No. IPR2018-00234
`
`US. Patent No. 8 805 948
`
`(ii) Where confidentiality is alleged as to some but not all of the information
`submitted to the Board, the submitting party shall file confidential and non-
`confidential versions of its submission, together with a Motion to Seal the
`confidential version setting forth the reasons why the information redacted from the
`non-confidential version is confidential and should not be made available to the
`
`public. The nonconfidential version of the submission shall clearly indicate the
`locations of information that has been redacted. The confidential version of the
`
`submission shall be filed under seal. The redacted information shall remain under
`
`seal unless, upon motion of a party and after a hearing on the issue, or sua sponte,
`the Board determines that some or all of the redacted information does not qualify
`for confidential treatment.
`
`(B) Documents and Information Exchanged Among the Parties. Information
`designated as confidential that is disclosed to another party during discovery or
`other proceedings before the Board shall be clearly marked as
`
`“CONFIDENTIALleriGONPIDEN—T-LAJ: ” “CONFIDENTIAL —
`
`ATTORNEYS’ EYES ONLY,” or “PETITIONER’S RESTRICTED —
`
`ATTORNEYS’ EYES ONLY” and shall be produced in a manner that maintains
`its confidentiality. For clarigg, nothing precludes a 9am from sharing any of its
`own protected information.
`
`(j) Standard Acknowledgement ofProtective Order. The following form may be
`used to acknowledge a protective order and gain access to information covered by
`the protective order:
`
`IIUI
`
`INTEL EX. 1401.006
`
`INTEL EX. 1401.006
`
`

`

`[CAPTION]
`
`Standard Acknowledgment for Access to Protective Order Material
`
`I ____, affirm that I have read the Protective Order; that I will abide by its terms;
`that I will use the confidential information only in connection with this proceeding
`and for no other purpose; that I will only allow access to support staff who are
`reasonably necessary to assist me in this proceeding; that prior to any disclosure to
`such support staff I informed or will inform them of the requirements of the
`Protective Order; that I am personally responsible for the requirements of the terms
`of the Protective Order and I agree to submit to the jurisdiction of the Office and the
`United States District Court for the Eastern District of Virginia for purposes of
`enforcing the terms of the Protective Order and providing remedies for its breach.
`
`[Signature]
`
`INTEL EX. 1401.007
`
`

`

`Case No. IPR2018-00234
`US. Patent No. 8 805 948
`
`6;. The protective orders in the co-pending district court litigations (2:16-cv-
`00693, 2:16-cv—00692, 2:16-cv—00695) are not affected by this Stipulated
`Protective
`
`Order.
`
`||\]
`
`INTEL EX. 1401.008
`
`INTEL EX. 1401.008
`
`

`

`Summary report:
`Litéra® Change-Pro TDC 10.1.0.800 Document comparison done on
`12/13/2018 11:09:38 AM
`
`S le name: Default S le
`
`Intelli_ent Table Com 0 arison: Active
`
` _—
`
`—_
`Move To
`—_
`Table Insert
`—_
`—_
`Table moves to
`—_
`—_
`—-—-__
`Embedded Gra .hics Visio, ChemDraw, Ima es etc.
`Embedded Excel
`—_
`__
`Format Chan es
`_——
`Total Chan_es:
`
`Ori_inal filename: l - Current Protective Order 948 . ndt
`Modified filename: 3— St' oulated Protective Order - Revised 948. df
`
`Chan 1 es:
`Add
`
`INTEL EX. 1401.009
`
`INTEL EX. 1401.009
`
`